文献速递功能神经外科

内神经松解术治疗三叉神经痛:系统综述

Internal Neurolysis for the Treatment of Trigeminal Neuralgia: A Systematic Review.
PubMed 文献 · World Neurosurg · 2021-11-22

本系统综述汇总2000至2021年评估内神经松解术(IN)治疗三叉神经痛的研究,共纳入12项研究、520例患者,其中384例接受IN(平均年龄53.8岁,平均随访36.5个月)。83.7%(范围72%-93.8%)患者获得优至良结局(BNI-PS I-II级),术后平均96%出现面部麻木,随访时仅1.75%-10%残留。作者认为IN对无血管压迫及潜在复发病例是有前景的手术方式,并发症总体有限但需进一步研究。

要点

  • 384例IN患者中83.7%(范围72%-93.8%)达BNI-PS I-II级优至良结局。
  • 术后平均96%出现面部麻木,随访时仅1.75%-10%残留,多数不造成明显困扰。
  • 作者认为IN对无血管压迫及潜在复发病例有前景,并发症需进一步研究。

核心结论

  • IN是治疗无血管压迫及潜在复发性三叉神经痛的有前景手术方式。
  • 并发症总体有限,但需进一步研究。

研究设计与样本

  • 系统综述,汇总2000至2021年评估IN治疗三叉神经痛的研究并独立评审。
  • 共12项研究、520例患者,其中384例接受IN,平均年龄53.8岁(范围46-61.4岁),平均随访36.5个月。
  • 术前症状约持续55.0个月,疼痛以V2和V3分布为主(26.8%),其次为其他分布。

主要发现

  • 83.7%(范围72%-93.8%)的患者获得优至良结局(BNI-PS I-II级)。
  • 1年疼痛结局:优为58%-78.4%,良或更好为77%-93.75%,中或更好为80%-93.75%。
  • 术后平均96%的患者出现面部麻木,随访时仅1.75%-10%残留,多数残留麻木未对患者造成明显困扰。
  • 还评估了IN与复发MVD、IN与射频消融、无血管压迫时IN的效果、IN联合与不联合MVD的亚组比较。

局限性

  • 并发症总体有限,但需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Trigeminal neuralgia (TN) remains a challenging disease with debilitating symptoms and variable efficacy in terms of treatment options. Microvascular decompression (MVD) with internal neurolysis (IN) is an alternative treatment that might benefit patients but has limited understanding. We performed a systematic review of IN for the treatment of TN. METHODS: Studies from 2000 to 2021 that had assessed IN for TN were aggregated and independently reviewed. RESULTS: A total of 520 patients in 12 studies were identified, with 384 who had undergone IN (mean age, 53.8 years; range, 46-61.4 years; mean follow-up, 36.5 months). Preoperative symptoms had been present for ∼55.0 months before treatment, and pain was predominantly in V2 and V3 (26.8%), followed by other distributions. Of the patients, 83.7% (range, 72%-93.8%) had had an excellent to good outcome (Barrow Neurological Institute pain scale score [BNI-PS], I-II). The pain outcomes at 1 year were excellent for 58%-78.4%, good or better for 77%-93.75%, and fair or better for 80%-93.75% of the patients. On average, facial numbness after IN was experienced by 96% of the patients. However, at follow-up, facial numbness remained in only 1.75%-10%. Most of the remaining numbness was not significantly distressing to the patients. Subgroup comparisons of IN versus recurrent MVD, IN versus radiofrequency ablation, the effects of IN in the absence of vascular compression, and IN with and without MVD were also evaluated. CONCLUSIONS: IN represents a promising surgical intervention for TN in the absence of vascular compression and for potential cases of recurrence. Complications were limited in general but require further study.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Sabourin V, Lavergne P, Mazza J, et al. Internal Neurolysis for the Treatment of Trigeminal Neuralgia: A Systematic Review. World Neurosurg. 2021. PMID: 34823039. doi:10.1016/j.wneu.2021.11.068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。